Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

Saynor said Sandoz's North America President Keren Haruvi, who also chairs the AAM, has been meeting with White House officials nearly every week to discuss pharmaceutical imports and U.S ...

Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...

Pharma companies involved in Vietnam are making more strategic moves to ease potential impacts in the face of US tariff ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...

Noting that despite successes and benefits, the modern U.S. pharmaceutical market is fraught with challenges, notably near-historic levels of ongoing and active medicine shortages, Sandoz said ...

Sandoz is one of the largest off-patent pharmaceutical manufacturers in the world. It generates roughly 75% of sales from generic drugs with the remainder from biosimilars and has a significant ...

Swiss pharmaceutical company Sandoz is launching a generic semaglutide, the main ingredient of Ozempic, in the U.S. when the market opens in 2030, Bloomberg reported Sept. 3. The company first ...

Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 billion). The Sandoz Family Foundation, through the vehicle Emasan AG ...